Skip to main content
    F

    Femasys Inc (FEMY)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $1.28
    -0.14 (-9.86%)

    Market Cap: $11.89M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Femasys Inc (FEMY) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Femasys are Retractable Technologies (RVP), Milestone Scientific (MLSS) and Nephros (NEPH). By market cap, Femasys ranks 12th of the 13 companies on this page; Merit Medical Systems (MMSI) is the largest at $5.19B. The median P/E of the 3 companies with a P/E is 21.2x.

    Peer Comparison

    FEMY's ROIC of -40.0% is below the peer median of 7.0%, and its revenue growth of -18.9% is below the median of 7.9%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Femasys (FEMY)$11.89MN/A5.6x0.0%-40.0%-18.9%0.00%
    Retractable Technologies Inc (RVP)$16.76MN/A0.4x-9.9%-31.4%-31.1%0.00%
    Milestone Scientific (MLSS)$27.82MN/A3.0x-44.0%N/A22.3%0.00%
    Nephros Inc (NEPH)$33.15M23.1x1.5x8.8%10.8%18.0%0.00%
    Harvard Bioscience Inc (HBIO)$42.94MN/A0.5x-13.2%-10.2%7.8%0.00%
    Merit Medical Systems Inc (MMSI)$5.19B21.2x3.2x9.9%7.0%8.4%0.00%
    Daxor Corporation (DXR)$49.51MN/A266.9x19861.0%N/A25.5%0.00%
    Dare Bioscience Inc (DARE)$12.93MN/A6.4x0.0%N/A499.6%0.00%
    FibroBiologics, Inc. Common Stock (FBLG)$6.57MN/AN/A0.0%N/A0.0%0.00%
    Fractyl Health, Inc. Common Stock (GUTS)$11.99MN/AN/A0.0%-245.8%-57.1%0.00%
    Sanara Medtech Inc (SMTI)$297.06MN/A2.6x-2.7%16.9%8.0%0.00%
    Embecta Corp (EMBC)$366.02M3.1x0.3x8.6%18.4%-8.1%0.64%
    TherapeuticsMD Inc (TXMD)$21.64MN/A5.6x-6.6%N/A-8.7%0.00%
    Peer median$30.49M21.2x2.8x0.0%7.0%7.9%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Femasys, ranked by how closely their business, size, sector and industry match. The largest group, 8 of the 12, is in Medical Instruments & Supplies; the other 4 span 2 industries.

    CompanyAboutPeers
    Retractable Technologies Inc (RVP)Medical Instruments & Supplies
    Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United...
    RVP competitors
    Milestone Scientific (MLSS)Medical Instruments & Supplies
    Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States, China...
    MLSS competitors
    Nephros Inc (NEPH)Medical Instruments & Supplies
    Nephros, Inc., a commercial stage company, develops and sells water solutions to the medical and commercial markets in the United States.
    NEPH competitors
    Harvard Bioscience Inc (HBIO)Medical Instruments & Supplies
    Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enable fundamental research, discovery...
    HBIO competitors
    Merit Medical Systems Inc (MMSI)Medical Instruments & Supplies
    Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology...
    MMSI competitors
    Daxor Corporation (DXR)Medical Instruments & Supplies
    Daxor Corporation, a medical device company, provides cryobank and biotechnology services in the United States.
    Dare Bioscience Inc (DARE)Biotechnology
    Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's health products in the United States.
    DARE competitors
    FibroBiologics, Inc. Common Stock (FBLG)Biotechnology
    FibroBiologics, Inc. is an innovative biotechnology company dedicated to advancing regenerative medicine through its proprietary fibroblast cell technology...
    FBLG competitors
    Fractyl Health, Inc. Common Stock (GUTS)Biotechnology
    Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity.
    GUTS competitors
    Sanara Medtech Inc (SMTI)Medical Instruments & Supplies
    Sanara MedTech Inc. develops, markets and distributes skin and wound care products to physicians, hospitals, clinics...
    SMTI competitors
    Embecta Corp (EMBC)Medical Instruments & Supplies
    Embecta Corp (EMBC) is a leading medical technology company specializing in innovative insulin delivery systems aimed at enhancing diabetes management.
    EMBC competitors
    TherapeuticsMD Inc (TXMD)Drug Manufacturers - Specialty & Generic
    TherapeuticsMD, Inc. is a women's healthcare company in the United States. The company is headquartered in Boca Raton, Florida.
    TXMD competitors

    Frequently Asked Questions About FEMY

    Who are Femasys' main competitors?

    The companies most similar to Femasys include Retractable Technologies (RVP), Milestone Scientific (MLSS), Nephros (NEPH), Harvard Bioscience (HBIO) and Merit Medical Systems (MMSI), listed from the closest match.

    Who is Femasys' biggest competitor?

    Merit Medical Systems (MMSI) is the largest of the similar companies at $5.19B; Retractable Technologies (RVP) is the closest match by business profile, size, sector and industry.

    How does FEMY stock compare with its competitors?

    FEMY's P/S is 5.6x against a peer median of 2.8x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Femasys' competitors pays a higher dividend?

    Femasys pays no dividend. Embecta (EMBC) has a higher forward dividend yield; Embecta (EMBC) has the highest at 0.64%.

    Is Femasys bigger than its competitors?

    No. Femasys is 12th by market cap among the 13 companies on this page; the largest is Merit Medical Systems (MMSI) at $5.19B.